We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · August 03, 2020

Immune Checkpoint Inhibitors for Papillary Renal Cell Carcinoma

European Journal of Cancer

 

Additional Info

European Journal of Cancer
Are Immune Checkpoint Inhibitors a Valid Option for Papillary Renal Cell Carcinoma? A Multicentre Retrospective Study
Eur. J. Cancer 2020 Jul 09;136(xx)76-83, M de Vries-Brilland, M Gross-Goupil, V Seegers, E Boughalem, B Beuselinck, C Thibault, C Chevreau, S Ladoire, P Barthélémy, S Negrier, D Borchiellini, O Huillard, L Geoffrois, G Gravis, C Saldana, A Thiery-Vuillemin, B Escudier, A Ravaud, L Albiges

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Renal Cell Carcinoma Center of Excellence

Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.


Further Reading